{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:53:17Z","timestamp":1793044397442,"version":"4.5.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272435"],"award-info":[{"award-number":["82272435"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82302602"],"award-info":[{"award-number":["82302602"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pancreatic ductal adenocarcinoma (PDAC) cells undergo mitochondrial metabolic reprogramming to support their proliferation. However, the mechanisms by which mitochondrial protein quality control (MPQC) regulates cell metabolism remain unclear. Here, we found that c-Myc promotes PDAC cell proliferation by transcriptionally upregulating the expression of GRPEL1, an essential MPQC component. Mechanistically, c-Myc-regulated GRPEL1 maintains oxidative phosphorylation (OXPHOS) and minimizes ROS accumulation, thereby facilitating de novo fatty acid (FA) synthesis through the transcriptional upregulation of fatty acid synthase (FASN) expression. Targeting the c-Myc\/GRPEL1 axis to block FASN-regulated FA synthesis inhibited PDAC cell proliferation and tumor growth in both cell models and patient-derived organoids (PDOs), whereas FA supplementation partially reversed this inhibitory effect. Clinically, c-Myc expression is positively associated with the levels of MPQC components in pancreatic ductal cells, with GRPEL1 ranking among the top hits. Furthermore, c-Myc, GRPEL1, and FASN are all expressed at higher levels in PDAC tissues than in peri-tumoral pancreatic tissues, and both c-Myc and GRPEL1 expression levels are positively correlated with that of FASN. These findings suggest that therapeutic inhibition of FA synthesis may be promising for treating PDAC patients with active c-Myc\/GRPEL1\/FASN signaling. Overall, this study demonstrates that FA synthesis mediated by the c-Myc\/GRPEL1\/FASN axis is essential for PDAC growth.<\/jats:p>","DOI":"10.1038\/s41419-026-08439-0","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T10:35:53Z","timestamp":1770287753000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["c-Myc\/GRPEL1 maintains fatty acid synthesis via FASN to support PDAC cell proliferation"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2423-9206","authenticated-orcid":false,"given":"Jing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keke","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangze","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanjuan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hezhi","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0947-5091","authenticated-orcid":false,"given":"Wei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"key":"8439_CR1","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41586-019-0891-2","volume":"566","author":"HA Messal","year":"2019","unstructured":"Messal HA, Alt S, Ferreira RMM, Gribben C, Wang VM, Cotoi CG, et al. Tissue curvature and apicobasal mechanical tension imbalance instruct cancer morphogenesis. Nature. 2019;566:126\u201330.","journal-title":"Nature"},{"key":"8439_CR2","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41586-021-03916-2","volume":"597","author":"P Neuh\u00f6fer","year":"2021","unstructured":"Neuh\u00f6fer P, Roake CM, Kim SJ, Lu RJ, West RB, Charville GW, et al. Acinar cell clonal expansion in pancreas homeostasis and carcinogenesis. Nature. 2021;597:715\u20139.","journal-title":"Nature"},{"key":"8439_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-63864-7","volume":"16","author":"S S\u00f6derqvist","year":"2025","unstructured":"S\u00f6derqvist S, Viljamaa A, Geyer N, Keller AL, Ruksha K, Strell C, et al. An injury-associated lobular microniche is associated with the classical tumor cell phenotype in pancreatic cancer. Nat Commun. 2025;16:8307.","journal-title":"Nat Commun"},{"key":"8439_CR4","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","volume":"186","author":"CJ Halbrook","year":"2023","unstructured":"Halbrook CJ, Lyssiotis CA, Pasca di Magliano M, Maitra A. Pancreatic cancer: advances and challenges. Cell. 2023;186:1729\u201354.","journal-title":"Cell"},{"key":"8439_CR5","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1053\/j.gastro.2022.03.056","volume":"163","author":"LD Wood","year":"2022","unstructured":"Wood LD, Canto MI, Jaffee EM, Simeone DM. Pancreatic cancer: pathogenesis, screening, diagnosis, and treatment. Gastroenterology. 2022;163:386\u2013402.e1.","journal-title":"Gastroenterology"},{"key":"8439_CR6","first-page":"Cd011044","volume":"12","author":"L Haggstrom","year":"2024","unstructured":"Haggstrom L, Chan WY, Nagrial A, Chantrill LA, Sim HW, Yip D, et al. Chemotherapy and radiotherapy for advanced pancreatic cancer. Cochrane Database Syst Rev. 2024;12:Cd011044.","journal-title":"Cochrane Database Syst Rev"},{"key":"8439_CR7","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1001\/jama.2016.4324","volume":"315","author":"P Hammel","year":"2016","unstructured":"Hammel P, Huguet F, van Laethem JL, Goldstein D, Glimelius B, Artru P, et al. Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without erlotinib: the LAP07 randomized clinical trial. JAMA. 2016;315:1844\u201353.","journal-title":"JAMA"},{"key":"8439_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105278","volume":"107","author":"N V\u00e1zquez-Bell\u00f3n","year":"2024","unstructured":"V\u00e1zquez-Bell\u00f3n N, Mart\u00ednez-Bosch N, Garc\u00eda de Frutos P, Navarro P. Hallmarks of pancreatic cancer: spotlight on TAM receptors. eBioMedicine. 2024;107:105278.","journal-title":"eBioMedicine"},{"key":"8439_CR9","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1038\/s43018-022-00463-1","volume":"3","author":"CJ Halbrook","year":"2022","unstructured":"Halbrook CJ, Thurston G, Boyer S, Anaraki C, Jim\u00e9nez JA, McCarthy A, et al. Differential integrated stress response and asparagine production drive symbiosis and therapy resistance of pancreatic adenocarcinoma cells. Nat Cancer. 2022;3:1386\u2013403.","journal-title":"Nat Cancer"},{"key":"8439_CR10","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/978-1-0716-3633-6_14","volume":"2755","author":"V Chumak","year":"2024","unstructured":"Chumak V, Rajacharya GH, Singh PK. Metabolomic investigations into hypoxia-mediated metabolic reprogramming of pancreatic cancer cells. Methods Mol Biol. 2024;2755:191\u2013200.","journal-title":"Methods Mol Biol"},{"key":"8439_CR11","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.molmed.2024.03.008","volume":"30","author":"MC De Santis","year":"2024","unstructured":"De Santis MC, Bockorny B, Hirsch E, Cappello P, Martini M. Exploiting pancreatic cancer metabolism: challenges and opportunities. Trends Mol Med. 2024;30:592\u2013604.","journal-title":"Trends Mol Med"},{"key":"8439_CR12","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/s41556-018-0124-1","volume":"20","author":"JB Spinelli","year":"2018","unstructured":"Spinelli JB, Haigis MC. The multifaceted contributions of mitochondria to cellular metabolism. Nat Cell Biol. 2018;20:745\u201354.","journal-title":"Nat Cell Biol"},{"key":"8439_CR13","doi-asserted-by":"crossref","unstructured":"Jadiya P, Tomar D. Mitochondrial protein quality control mechanisms. Genes. 2020;11:563.","DOI":"10.3390\/genes11050563"},{"key":"8439_CR14","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41580-020-00300-2","volume":"22","author":"J Song","year":"2021","unstructured":"Song J, Herrmann JM, Becker T. Quality control of the mitochondrial proteome. Nat Rev Mol Cell Biol. 2021;22:54\u201370.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8439_CR15","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.trecan.2021.08.008","volume":"7","author":"JR Inigo","year":"2021","unstructured":"Inigo JR, Kumar R, Chandra D. Targeting the mitochondrial unfolded protein response in cancer: opportunities and challenges. Trends Cancer. 2021;7:1050\u20133.","journal-title":"Trends Cancer"},{"key":"8439_CR16","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1016\/j.cell.2024.04.037","volume":"187","author":"A Suomalainen","year":"2024","unstructured":"Suomalainen A, Nunnari J. Mitochondria at the crossroads of health and disease. Cell. 2024;187:2601\u201327.","journal-title":"Cell"},{"key":"8439_CR17","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/med.21929","volume":"43","author":"J Zhang","year":"2023","unstructured":"Zhang J, Qiao W, Luo Y. Mitochondrial quality control proteases and their modulation for cancer therapy. Med Res Rev. 2023;43:399\u2013436.","journal-title":"Med Res Rev"},{"key":"8439_CR18","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1146\/annurev-biochem-013118-111540","volume":"89","author":"R Lill","year":"2020","unstructured":"Lill R, Freibert SA. Mechanisms of mitochondrial iron-sulfur protein biogenesis. Annu Rev Biochem. 2020;89:471\u201399.","journal-title":"Annu Rev Biochem"},{"key":"8439_CR19","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41392-025-02311-x","volume":"10","author":"H Du","year":"2025","unstructured":"Du H, Xu T, Yu S, Wu S, Zhang J. Mitochondrial metabolism and cancer therapeutic innovation. Signal Transduct Target Ther. 2025;10:245.","journal-title":"Signal Transduct Target Ther"},{"key":"8439_CR20","doi-asserted-by":"crossref","unstructured":"Ren X, Yan J, Zhao Q, Bao X, Han X, Zheng C, et al. The Fe\u2013S cluster assembly protein IscU2 increases \u03b1-ketoglutarate catabolism and DNA 5mC to promote tumor growth. Cell Disc. 2023;9:76.","DOI":"10.1038\/s41421-023-00558-8"},{"key":"8439_CR21","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.devcel.2021.02.009","volume":"56","author":"MYW Ng","year":"2021","unstructured":"Ng MYW, Wai T, Simonsen A. Quality control of the mitochondrion. Dev Cell. 2021;56:881\u2013905.","journal-title":"Dev Cell"},{"key":"8439_CR22","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41556-024-01590-w","volume":"27","author":"N Pfanner","year":"2025","unstructured":"Pfanner N, den Brave F, Becker T. Mitochondrial protein import stress. Nat Cell Biol. 2025;27:188\u2013201.","journal-title":"Nat Cell Biol"},{"key":"8439_CR23","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201911845","volume":"12","author":"T Zhang","year":"2020","unstructured":"Zhang T, Li N, Sun C, Jin Y, Sheng X. MYC and the unfolded protein response in cancer: synthetic lethal partners in crime?. EMBO Mol Med. 2020;12:e11845.","journal-title":"EMBO Mol Med"},{"key":"8439_CR24","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ebiom.2019.09.054","volume":"49","author":"P Chen","year":"2019","unstructured":"Chen P, Wang B, Mo Q, Wu P, Fang Y, Tian Y, et al. The LIV-1-GRPEL1 axis adjusts cell fate during anti-mitotic agent-damaged mitosis. eBioMedicine. 2019;49:26\u201339.","journal-title":"eBioMedicine"},{"key":"8439_CR25","doi-asserted-by":"publisher","DOI":"10.1126\/science.adf2034","volume":"388","author":"EM Walker","year":"2025","unstructured":"Walker EM, Pearson GL, Lawlor N, Stendahl AM, Lietzke A, Sidarala V, et al. Retrograde mitochondrial signaling governs the identity and maturity of metabolic tissues. Science. 2025;388:eadf2034.","journal-title":"Science"},{"key":"8439_CR26","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.bbamcr.2012.02.010","volume":"1833","author":"SM Jazwinski","year":"2013","unstructured":"Jazwinski SM. The retrograde response: when mitochondrial quality control is not enough. Biochim Biophys Acta. 2013;1833:400\u20139.","journal-title":"Biochim Biophys Acta"},{"key":"8439_CR27","doi-asserted-by":"crossref","unstructured":"Xie M, Wu X, Liu X, Li L, Gu F, Tao X, et al. GrpEL1 overexpression mitigates hippocampal neuron damage via mitochondrial unfolded protein response after experimental status epilepticus. Neurobiol Dis. 2025;206:106838.","DOI":"10.1016\/j.nbd.2025.106838"},{"key":"8439_CR28","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.brainresbull.2022.01.014","volume":"181","author":"C Ma","year":"2022","unstructured":"Ma C, Gao B, Wang Z, You W, Yu Z, Shen H, et al. GrpEL1 regulates mitochondrial unfolded protein response after experimental subarachnoid hemorrhage in vivo and in vitro. Brain Res Bull. 2022;181:97\u2013108.","journal-title":"Brain Res Bull"},{"key":"8439_CR29","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/s42003-022-04034-z","volume":"5","author":"N Neupane","year":"2022","unstructured":"Neupane N, Rajendran J, Kvist J, Harjuhaahto S, Hu B, Kinnunen V, et al. Inter-organellar and systemic responses to impaired mitochondrial matrix protein import in skeletal muscle. Commun Biol. 2022;5:1060.","journal-title":"Commun Biol"},{"key":"8439_CR30","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s42255-025-01224-x","volume":"7","author":"AM Casey","year":"2025","unstructured":"Casey AM, Ryan DG, Prag HA, Chowdhury SR, Marques E, Turner K, et al. Pro-inflammatory macrophages produce mitochondria-derived superoxide by reverse electron transport at complex I that regulates IL-1\u03b2 release during NLRP3 inflammasome activation. Nat Metab. 2025;7:493\u2013507.","journal-title":"Nat Metab"},{"key":"8439_CR31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2219352120","volume":"121","author":"XN Wu","year":"2024","unstructured":"Wu XN, Li JY, He Q, Li BQ, He YH, Pan X, et al. Targeting the PHF8\/YY1 axis suppresses cancer cell growth through modulation of ROS. Proc Natl Acad Sci USA. 2024;121:e2219352120.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8439_CR32","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.cmet.2019.07.012","volume":"30","author":"AM Gouw","year":"2019","unstructured":"Gouw AM, Margulis K, Liu NS, Raman SJ, Mancuso A, Toal GG, et al. The MYC oncogene cooperates with sterol-regulated element-binding protein to regulate lipogenesis essential for neoplastic growth. Cell Metab. 2019;30:556\u201372.e5.","journal-title":"Cell Metab"},{"key":"8439_CR33","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13046-020-01579-x","volume":"39","author":"L Gao","year":"2020","unstructured":"Gao L, Xu Z, Huang Z, Tang Y, Yang D, Huang J, et al. CPI-613 rewires lipid metabolism to enhance pancreatic cancer apoptosis via the AMPK-ACC signaling. J Exp Clin Cancer Res. 2020;39:73.","journal-title":"J Exp Clin Cancer Res"},{"key":"8439_CR34","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.omto.2019.07.005","volume":"14","author":"H Zhao","year":"2019","unstructured":"Zhao H, Wu S, Li H, Duan Q, Zhang Z, Shen Q, et al. ROS\/KRAS\/AMPK signaling contributes to gemcitabine-induced stem-like cell properties in pancreatic cancer. Mol Ther Oncolytics. 2019;14:299\u2013312.","journal-title":"Mol Ther Oncolytics"},{"key":"8439_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103230","volume":"74","author":"D Cheng","year":"2024","unstructured":"Cheng D, Zhang M, Zheng Y, Wang M, Gao Y, Wang X, et al. \u03b1-Ketoglutarate prevents hyperlipidemia-induced fatty liver mitochondrial dysfunction and oxidative stress by activating the AMPK-pgc-1\u03b1\/Nrf2 pathway. Redox Biol. 2024;74:103230.","journal-title":"Redox Biol"},{"key":"8439_CR36","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1016\/j.celrep.2017.06.014","volume":"19","author":"M Morgenstern","year":"2017","unstructured":"Morgenstern M, Stiller SB, L\u00fcbbert P, Peikert CD, Dannenmaier S, Drepper F, et al. Definition of a high-confidence mitochondrial proteome at quantitative scale. Cell Rep. 2017;19:2836\u201352.","journal-title":"Cell Rep"},{"key":"8439_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00359-0","volume":"8","author":"FN V\u00f6gtle","year":"2017","unstructured":"V\u00f6gtle FN, Burkhart JM, Gonczarowska-Jorge H, K\u00fcc\u00fckk\u00f6se C, Taskin AA, Kopczynski D, et al. Landscape of submitochondrial protein distribution. Nat Commun. 2017;8:290.","journal-title":"Nat Commun"},{"key":"8439_CR38","doi-asserted-by":"publisher","first-page":"D1541","DOI":"10.1093\/nar\/gkaa1011","volume":"49","author":"S Rath","year":"2021","unstructured":"Rath S, Sharma R, Gupta R, Ast T, Chan C, Durham TJ, et al. MitoCarta3.0: an updated mitochondrial proteome now with sub-organelle localization and pathway annotations. Nucleic Acids Res. 2021;49:D1541\u2013d7.","journal-title":"Nucleic Acids Res"},{"key":"8439_CR39","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1016\/j.cmet.2021.11.001","volume":"33","author":"M Morgenstern","year":"2021","unstructured":"Morgenstern M, Peikert CD, L\u00fcbbert P, Suppanz I, Klemm C, Alka O, et al. Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context. Cell Metab. 2021;33:2464\u201383.e18.","journal-title":"Cell Metab"},{"key":"8439_CR40","doi-asserted-by":"crossref","unstructured":"Wei L, Hong B, Zhang X, Cao R, Huang L, Xu C, et al. Mitochondrial homeostasis in cancer: functions and targeted therapies. Crit Rev Oncol\/Hematol. 2025;215:104899.","DOI":"10.1016\/j.critrevonc.2025.104899"},{"key":"8439_CR41","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.trecan.2022.08.001","volume":"8","author":"M Kim","year":"2022","unstructured":"Kim M, Mahmood M, Reznik E, Gammage PA. Mitochondrial DNA is a major source of driver mutations in cancer. Trends Cancer. 2022;8:1046\u201359.","journal-title":"Trends Cancer"},{"key":"8439_CR42","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.molcel.2016.02.011","volume":"61","author":"WX Zong","year":"2016","unstructured":"Zong WX, Rabinowitz JD, White E. Mitochondria and cancer. Mol Cell. 2016;61:667\u201376.","journal-title":"Mol Cell"},{"key":"8439_CR43","volume":"11","author":"WL Hong","year":"2024","unstructured":"Hong WL, Huang H, Zeng X, Duan CY. Targeting mitochondrial quality control: new therapeutic strategies for major diseases. Mil Med Res. 2024;11:59.","journal-title":"Mil Med Res"},{"key":"8439_CR44","doi-asserted-by":"crossref","unstructured":"Bhardwaj V, He J. Reactive oxygen species, metabolic plasticity, and drug resistance in cancer. Int J Mol Sci. 2020;21:3412.","DOI":"10.3390\/ijms21103412"},{"key":"8439_CR45","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3389\/fonc.2017.00159","volume":"7","author":"TC Kenny","year":"2017","unstructured":"Kenny TC, Manfredi G, Germain D. The mitochondrial unfolded protein response as a non-oncogene addiction to support adaptation to stress during transformation in cancer and beyond. Front Oncol. 2017;7:159.","journal-title":"Front Oncol"},{"key":"8439_CR46","doi-asserted-by":"publisher","first-page":"5815","DOI":"10.1039\/D0FO00554A","volume":"11","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Li MZ, Talukder M, Luo Y, Shen Y, Wang HR, et al. Effect of mitochondrial quality control on the lycopene antagonizing DEHP-induced mitophagy in spermatogenic cells. Food Funct. 2020;11:5815\u201326.","journal-title":"Food Funct"},{"key":"8439_CR47","volume":"11","author":"BH Liu","year":"2024","unstructured":"Liu BH, Xu CZ, Liu Y, Lu ZL, Fu TL, Li GR, et al. Mitochondrial quality control in human health and disease. Mil Med Res. 2024;11:32.","journal-title":"Mil Med Res"},{"key":"8439_CR48","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/s41556-023-01155-3","volume":"25","author":"T Fu","year":"2023","unstructured":"Fu T, Sun W, Xue J, Zhou Z, Wang W, Guo Q, et al. Proteolytic rewiring of mitochondria by LONP1 directs cell identity switching of adipocytes. Nat Cell Biol. 2023;25:848\u201364.","journal-title":"Nat Cell Biol"},{"key":"8439_CR49","doi-asserted-by":"crossref","unstructured":"Leeming PJ, Mercuri-Svik J, Stojanovski D. From biogenesis to breakdown: how protein biogenesis and quality control failures drive mitochondrial disease. Mol Cell Biol. 2025;46:1\u201327.","DOI":"10.1080\/10985549.2025.2566671"},{"key":"8439_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2023.101859","volume":"79","author":"A Janz","year":"2024","unstructured":"Janz A, Walz K, Cirnu A, Surjanto J, Urlaub D, Leskien M, et al. Mutations in DNAJC19 cause altered mitochondrial structure and increased mitochondrial respiration in human iPSC-derived cardiomyocytes. Mol Metab. 2024;79:101859.","journal-title":"Mol Metab"},{"key":"8439_CR51","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/bs.acr.2023.02.005","volume":"159","author":"AM Palma","year":"2023","unstructured":"Palma AM, Vudatha V, Peixoto ML, Madan E. Tumor heterogeneity: an oncogenic driver of PDAC progression and therapy resistance under stress conditions. Adv Cancer Res. 2023;159:203\u201349.","journal-title":"Adv Cancer Res"},{"key":"8439_CR52","doi-asserted-by":"crossref","unstructured":"Garcia-Carbonero N, Li W, Cabeza-Morales M, Martinez-Useros J, Garcia-Foncillas J. New hope for pancreatic ductal adenocarcinoma treatment targeting endoplasmic reticulum stress response: a systematic review. Int J Mol Sci. 2018;19:2468.","DOI":"10.3390\/ijms19092468"},{"key":"8439_CR53","doi-asserted-by":"crossref","unstructured":"Mollinedo F, Gajate C. Direct endoplasmic reticulum targeting by the selective alkylphospholipid analog and antitumor ether lipid edelfosine as a therapeutic approach in pancreatic cancer. Cancers. 2021;13:4173.","DOI":"10.3390\/cancers13164173"},{"key":"8439_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2020.102070","volume":"89","author":"D Uprety","year":"2020","unstructured":"Uprety D, Adjei AA. KRAS: From undruggable to a druggable cancer target. Cancer Treat Rev. 2020;89:102070.","journal-title":"Cancer Treat Rev"},{"key":"8439_CR55","doi-asserted-by":"crossref","unstructured":"Gabay M, Li Y, Felsher DW. MYC activation is a hallmark of cancer initiation and maintenance. Cold Spring Harbor Perspect Med. 2014;4:a014241.","DOI":"10.1101\/cshperspect.a014241"},{"key":"8439_CR56","doi-asserted-by":"crossref","unstructured":"Chareddy YS, Huggins HP, Sahoo SS, Stanland LJ, Gutierrez-Ford C, Whately KM, et al. Inverted chimeric RNAi molecules synergistically cotarget MYC and KRAS in KRAS-driven cancers. J Clin Invest. 2025;135:e187204.","DOI":"10.1172\/JCI187204"},{"key":"8439_CR57","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1101\/gad.836800","volume":"14","author":"R Sears","year":"2000","unstructured":"Sears R, Nuckolls F, Haura E, Taya Y, Tamai K, Nevins JR. Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev. 2000;14:2501\u201314.","journal-title":"Genes Dev"},{"key":"8439_CR58","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.ccell.2018.10.001","volume":"34","author":"AV Vaseva","year":"2018","unstructured":"Vaseva AV, Blake DR, Gilbert TSK, Ng S, Hostetter G, Azam SH, et al. KRAS suppression-induced degradation of MYC is antagonized by a MEK5-ERK5 compensatory mechanism. Cancer Cell. 2018;34:807\u201322.e7.","journal-title":"Cancer Cell"},{"key":"8439_CR59","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1158\/2159-8290.CD-19-0435","volume":"10","author":"NM Sodir","year":"2020","unstructured":"Sodir NM, Kortlever RM, Barthet VJA, Campos T, Pellegrinet L, Kupczak S, et al. MYC instructs and maintains pancreatic adenocarcinoma phenotype. Cancer Discov. 2020;10:588\u2013607.","journal-title":"Cancer Discov"},{"key":"8439_CR60","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1038\/onc.2015.216","volume":"35","author":"E Hessmann","year":"2016","unstructured":"Hessmann E, Schneider G, Ellenrieder V, Siveke JT. MYC in pancreatic cancer: novel mechanistic insights and their translation into therapeutic strategies. Oncogene. 2016;35:1609\u201318.","journal-title":"Oncogene"},{"key":"8439_CR61","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/s42255-025-01261-6","volume":"7","author":"Z Ying","year":"2025","unstructured":"Ying Z, Xin Y, Liu Z, Tan T, Huang Y, Ding Y, et al. The mitochondrial unfolded protein response inhibits pluripotency acquisition and mesenchymal-to-epithelial transition in somatic cell reprogramming. Nat Metab. 2025;7:940\u201351.","journal-title":"Nat Metab"},{"key":"8439_CR62","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/s41556-019-0347-9","volume":"21","author":"F Tameire","year":"2019","unstructured":"Tameire F, Verginadis II, Leli NM, Polte C, Conn CS, Ojha R, et al. ATF4 couples MYC-dependent translational activity to bioenergetic demands during tumour progression. Nat Cell Biol. 2019;21:889\u201399.","journal-title":"Nat Cell Biol"},{"key":"8439_CR63","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41573-024-00979-4","volume":"23","author":"C Glorieux","year":"2024","unstructured":"Glorieux C, Liu S, Trachootham D, Huang P. Targeting ROS in cancer: rationale and strategies. Nat Rev Drug Discov. 2024;23:583\u2013606.","journal-title":"Nat Rev Drug Discov"},{"key":"8439_CR64","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.18632\/aging.101685","volume":"10","author":"G Lucarelli","year":"2018","unstructured":"Lucarelli G, Rutigliano M, Sallustio F, Ribatti D, Giglio A, Lepore Signorile M, et al. Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemoresistance, and mitochondrial dysfunction in clear cell renal cell carcinoma. Aging. 2018;10:3957\u201385.","journal-title":"Aging"},{"key":"8439_CR65","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.3892\/ijmm.2016.2574","volume":"37","author":"Y Tabuchi","year":"2016","unstructured":"Tabuchi Y, Uchiyama H, Zhao QL, Yunoki T, Andocs G, Nojima N, et al. Effects of nitrogen on the apoptosis of and changes in gene expression in human lymphoma U937 cells exposed to argon-based cold atmospheric pressure plasma. Int J Mol Med. 2016;37:1706\u201314.","journal-title":"Int J Mol Med"},{"key":"8439_CR66","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.7150\/ijbs.68873","volume":"18","author":"Q Li","year":"2022","unstructured":"Li Q, Tan JX, He Y, Bai F, Li SW, Hou YW, et al. Atractylenolide III ameliorates non-alcoholic fatty liver disease by activating hepatic adiponectin receptor 1-mediated AMPK pathway. Int J Biol Sci. 2022;18:1594\u2013611.","journal-title":"Int J Biol Sci"},{"key":"8439_CR67","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41556-020-0471-6","volume":"22","author":"X Li","year":"2020","unstructured":"Li X, Qian X, Wang B, Xia Y, Zheng Y, Du L, et al. Programmable base editing of mutated TERT promoter inhibits brain tumour growth. Nat Cell Biol. 2020;22:282\u20138.","journal-title":"Nat Cell Biol"},{"key":"8439_CR68","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/nbt.1511","volume":"26","author":"J Cox","year":"2008","unstructured":"Cox J, Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol. 2008;26:1367\u201372.","journal-title":"Nat Biotechnol"},{"key":"8439_CR69","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1093\/bioinformatics\/btq418","volume":"26","author":"J Xia","year":"2010","unstructured":"Xia J, Wishart DS. MetPA: a web-based metabolomics tool for pathway analysis and visualization. Bioinformatics. 2010;26:2342\u20134.","journal-title":"Bioinformatics"},{"key":"8439_CR70","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1093\/bioinformatics\/btt285","volume":"29","author":"W Luo","year":"2013","unstructured":"Luo W, Brouwer C. Pathview: an R\/bioconductor package for pathway-based data integration and visualization. Bioinformatics. 2013;29:1830\u20131.","journal-title":"Bioinformatics"},{"key":"8439_CR71","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1210\/endo.142.1.7863","volume":"142","author":"SP Cousin","year":"2001","unstructured":"Cousin SP, H\u00fcgl SR, Wrede CE, Kajio H, Myers MG Jr, Rhodes CJ. Free fatty acid-induced inhibition of glucose and insulin-like growth factor I-induced deoxyribonucleic acid synthesis in the pancreatic beta-cell line INS-1. Endocrinology. 2001;142:229\u201340.","journal-title":"Endocrinology"},{"key":"8439_CR72","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1158\/2159-8290.CD-18-0349","volume":"8","author":"H Tiriac","year":"2018","unstructured":"Tiriac H, Belleau P, Engle DD, Plenker D, Desch\u00eanes A, Somerville TDD, et al. Organoid profiling identifies common responders to chemotherapy in pancreatic cancer. Cancer Discov. 2018;8:1112\u201329.","journal-title":"Cancer Discov"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08439-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08439-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08439-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:04:19Z","timestamp":1770822259000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08439-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8439"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08439-0","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]},"assertion":[{"value":"8 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All experimental procedures involving animals and human-derived materials were conducted in accordance with the relevant guidelines and regulations. The animal study protocol was reviewed and approved by the Ethics Committee of Wenzhou Medical University (Approval No. wydw2023-0106). A human PDAC tissue microarray was ethically sourced from Shanghai Kaiwang Biotech Company (Approval No. KW2024126), and its use in this study complied with the associated ethical approval. Approval for the use of patient-derived organoids (obtained from Xellar Biosystems, Beijing) and all related experimental procedures was granted by the institutional ethics committee (Approval No. \u4f26\u5ba12020\u79d1060). Written informed consent was obtained from all patients for the use of their tissue in generating patient-derived organoids and for subsequent research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"205"}}